PZA-19893-44819
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 282 / NC
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2021-01-04
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-01-18
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-24
- 2021-04-12
-
2022-01-11
Survey response — 12 months, dose 2MedDRA: Delivery, No adverse event, Pregnancy, SARS-CoV-2 test negative — Feeling: GoodFree text: Became pregnant in 04/2021 after 2nd dose of Pfizer vaccine. Received booster vaccine and August 2021. Delivered a healthy baby end of December 2021. No adverse reactions to vaccine. Never had a positive covid test.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech |
Free text
Release 10 — 12 months, dose 2
Symptoms: Became pregnant in 04/2021 after 2nd dose of Pfizer vaccine. Received booster vaccine and August 2021. Delivered a healthy baby end of December 2021. No adverse reactions to vaccine. Never had a positive covid test.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | No adverse event | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release